Skip Navigation

	DLS Home
	Programs & Research
	DLS Branches
	Publications & Products
	Training Opportunities
	Employment
	Contact Us

	Cholesterol/Lipids
	Diabetes
	Genetics
	Hormone Standardization
	Laboratory Quality Assurance Programs
	Lead
	Micronutrients
	National Biomonitoring Program
	Newborn Screening
	Osteoporosis
	Responding to Chemical Terrorism
	Studies, Investigations & Emergencies
	Tobacco/Smoking

	CDC's Tobacco Laboratory PDF 1,534KB
	National Report on Human Exposure to Environmental Chemicals
	National Report on Biochemical Indicators of Diet and Nutrition
	Newborn Screening Laboratory Bulletin
	DLS Brochure

Tobacco/Smoking

Exposure to Tobacco Smoke and Harmful Substances in Tobacco

Biomonitoring also has been the driving force for assessing people's exposure to environmental tobacco smoke (ETS), which has been identified as causing cancer in people. Children are at particular risk for harm from ETS, which may aggravate asthma in children who have the disease and greatly increase the risk for bronchitis and pneumonia among young children.

The best way to measure individual exposure to ETS is to measure levels of a chemical called cotinine. This chemical is a metabolite of nicotine and is regarded as the best biological marker for tobacco smoke exposure for both smokers and nonsmokers exposed to ETS. People with higher cotinine levels have had more exposure to tobacco smoke than people with lower levels.

When CDC developed a method for measuring very low levels of cotinine in the U.S. population, it found that 88% of the population was exposed. Data were unavailable to document that people who thought they were exposed to ETS in the workplace actually had such exposure. CDC's study showed that people who reported more exposure to ETS in the workplace had measurably higher levels of cotinine, indicating higher actual exposure. These unique data provided important justification for establishing regulations restricting smoking in public buildings.

CDC has continued to measure the population's exposure to secondhand smoke and has found that since the 1990s secondhand smoke exposure has dropped dramatically in all segments of the population. The 2006 Surgeon General's Report (The Health Consequences of Involuntary Exposure to Tobacco Smoke) used these data to highlight the public health success in reducing nonsmokers' exposure to secondhand smoke in public places.

CDC's Environmental Health Laboratory also analyzes tobacco products and cigarette smoke for the presence of harmful substances and for substances that may influence the delivery of harmful substances to the body. For instance, the laboratory not only investigates the concentration of nicotine in cigarettes and smoke but also the factors or chemicals that influence the delivery of nicotine to people. In addition to nicotine, these harmful substances include nitrosamines; tar; pesticides; carbon monoxide; volatile organic compounds (benzene, for example); metals (such as cadmium and radioactive polonium); carbonyl compounds; and polycyclic aromatic hydrocarbons. Again, the laboratory's expertise in biomonitoring has been essential for determining the actual doses of many of these substances that get into people.

For More Information...

CDC Resources

• CDC's Tobacco Laboratory
  Division of Laboratory Sciences
  PDF 1,534KB
• Smoking & Tobacco Use
  Office on Smoking and Health

U.S. Federal Government Resources

• Smoking and Cancer Page
  National Cancer Institute (NCI)
• Report of Tar, Nicotine, Carbon Monoxide
  Federal Trade Commission (FTC)
• The Health Consequences of Involuntary Exposure to Tobacco Smoke
  Surgeon General's Report (2006)

Non-Federal Resources

• Healthy Living Tobacco Page
  Health Canada
• Clearing the Smoke: The Science Base for Tobacco Harm Reduction (2003)
  Institute of Medicine (IOM)
• Tobacco Free Initiative
  World Health Organization (WHO)